Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
2022 · Cancer Cell · 336 citations
https://doi.org/10.1016/j.ccell.2022.07.002
R
Rachel J. Cook
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
124
Papers
3.3K
Citations
15
h-index
26
i10-index
Rachel J. Cook is an academic researcher from University of Waterloo. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Hematopoietic Stem Cell Transplantation. The author has an h-index of 15, co-authored 106 publications.
ORCID: 0000-0001-7005-036XPapers by this author
worksGilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>
2024 · Journal of Clinical Oncology · 167 citations
https://doi.org/10.1200/jco.23.02474
Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years
2019 · Hematology/Oncology and Stem Cell Therapy · 6 citations
https://doi.org/10.1016/j.hemonc.2019.01.002
Dual FLT3/PIM inhibitor dapolsertib in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trial
2025 · Blood Neoplasia · 1 citations
https://doi.org/10.1016/j.bneo.2025.100178
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat